The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Reg...Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Genomic ... Yahoo! Finance, 4 days ago
Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
- Yahoo! Finance, 1 month ago
|
(3) images for "amgen rank" | ||||
BRIEF: Amgen Tour of California starts Sunday in EscondidoThe eighth Amgen Tour of California begins at 11:15 a.m. Sunday in Escondido, and for the first time the largest cycling stage race in the United States is traveling from south to north. The 750-mile trip will end May 19 in Santa Rosa. Matt ... Individual.com, 1 week ago
Amgen Tour of California starts Sunday in Escondido
Los Angeles Times, 1 week ago
2013 Amgen Tour of California will race from South to North
India Infoline, 1 month ago
Escondido to Host Official 2013 Amgen Tour of California Cha. . .
Equities.com, 1 month ago
|
Amgen To Set Up JV In ChinaAmgen to Set Up JV in China - By Zacks Investment Research Amgen ( AMGN ) recently announced its intention to set up a joint venture (JV) in China with Zhejiang Beta Pharma Co., Ltd. The JV will focus on the commercialization of Amgen's colorectal ... Seeking Alpha, 12 hours ago
Amgen to Set Up JV in China Zacks
Yahoo! Finance, 5 days ago
Amgen to Set Up JV in China - Analyst Blog
Nasdaq, 5 days ago
|
Q1 Revenue In-Line. Amgen Deal Is Encouraging ZacksBy Brian Marckx, CFAQ1 2013 RESULTS: Revenue In-Line, EPS Miss on Higher SG&A. Amgen Deal is Encouraging… Transgenomic (OTC:TBIO) reported financial results for Q1 ending March 31, 2013 on May 8th. Revenue was up 2% yoy and dead-on with our $7.4 ... Yahoo! Finance, 1 week ago
Positive Data on Amgen Candidate - Analyst Blog
Zacks.com, 1 month ago
Positive Data on Amgen Candidate - Analyst Blog
Quote.com India, 1 month ago
|
Tax Benefit Boosts Amgen Earnings ZacksAmgen (AMGN) reported first quarter 2013 earnings of $1.95 per share, 20 cents above the Zacks Consensus Estimate and 22.6% above the year-ago earnings. Tax benefits and a lower share count contributed to the year-over-year increase in earnings. The ... Yahoo! Finance, 3 weeks ago
Tax Benefit Boosts Amgen Earnings - Analyst Blog
Nasdaq, 3 weeks ago
Tax Benefit Boosts Amgen Earnings - Analyst Blog
Quote.com India, 3 weeks ago
|
Should You Buy Stock in Amgen After the Q1 Results Pullback?Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today. When it comes to biotechs, Amgen (NASDAQ: AMGN ) qualifies for the senior citizen discount. The company, founded way back in 1980, ... Motley Fool, 3 weeks ago
|
Will Amgen Beat Earnings? - Analyst BlogWe expect Amgen Inc. ( AMGN ) to beat earnings expectations when it reports first-quarter 2013 results after the closing bell on Apr 23, 2013. Why a Likely Positive Surprise? Our proven model shows that Amgen has the right combination of two ... Zacks.com, 3 weeks ago
Will Amgen Beat Earnings? Zacks
Yahoo! Finance, 3 weeks ago
More from: , Quote.com India...and 1 other sources
|
Santa Rosa Hosts Finish of 2013 Amgen Tour of California and Makes HistoryIn an unprecedented event the city of Santa Rosa, located in the heart of Northern California's Sonoma Wine Country will host the overall finish of the world wide prestigious Amgen Tour of California. The quaint town known as one of the top cycling ... Broadway World, 1 month ago
Santa Rosa Makes History as First Northern California City to Host Finish of 2013 Amgen Tour of California
Individual.com, 1 month ago
|
Patent loss pushes Lipitor to 17th rank in 2012, Abbott's Humira is world's largest selling drugThe most significant development in the global pharmaceutical market in 2012 is the displacement of Lipitor of Pfizer from its number one pharmaceutical product by Humira of Abbott. Lipitor, the cholesterol drug of Pfizer has been the top ... PharmaBiz, 1 month ago
|
Shares of Biogen Idec Rank the Highest in Terms of Free Cash Flow Per Share in the Biotechnology Industry (BIIB, AMGN, CELG, UTHR, ALXN)(SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.Biogen ... TMC Net, 1 month ago
Relatively High Free Cash Flow Per Share Detected in Shares of Biogen Idec in the Biotechnology Industry (BIIB, AMGN, CELG, UTHR, ALXN)
TMC Net, 1 week ago
|